These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15749155)

  • 1. A possible common pharmacophore in the non-peptide antagonists of the bradykinin B1 receptor.
    Marceau F
    Trends Pharmacol Sci; 2005 Mar; 26(3):116-8. PubMed ID: 15749155
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.
    Schnatbaum K; Schaudt M; Stragies R; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Zischinsky G
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1233-6. PubMed ID: 20036120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin B1 receptor antagonists: a patent update 2009 - 2012.
    Bozó É; Éles J; Keserű GM
    Expert Opin Ther Pat; 2012 Dec; 22(12):1443-52. PubMed ID: 23033970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.
    Ha SN; Hey PJ; Ransom RW; Bock MG; Su DS; Murphy KL; Chang R; Chen TB; Pettibone D; Hess JF
    Biochemistry; 2006 Dec; 45(48):14355-61. PubMed ID: 17128974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
    Kuduk SD; Chang RK; Ng C; Murphy KL; Ransom RW; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3925-9. PubMed ID: 15993596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
    Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
    Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
    J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment.
    Wong CT; Rowlands DK; Wong CH; Lo TW; Nguyen GK; Li HY; Tam JP
    Angew Chem Int Ed Engl; 2012 Jun; 51(23):5620-4. PubMed ID: 22532483
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
    Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
    Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin receptor antagonists--a review of the patent literature 2005-2008.
    Fincham CI; Bressan A; Paris M; Rossi C; Fattori D
    Expert Opin Ther Pat; 2009 Jul; 19(7):919-41. PubMed ID: 19552510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease.
    Duchene J; Ahluwalia A
    Curr Opin Pharmacol; 2009 Apr; 9(2):125-31. PubMed ID: 19124274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.
    Su DS; Markowitz MK; Murphy KL; Wan BL; Zrada MM; Harrell CM; O'Malley SS; Hess JF; Ransom RW; Chang RS; Wallace MA; Raab CE; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6045-8. PubMed ID: 15546726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
    Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
    Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
    Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation.
    Kuebler JF; Schremmer-Danninger E; Bhoola KD; Roscher AA; Messmer K; Hoffmann TF
    Biol Chem; 2003 Sep; 384(9):1311-9. PubMed ID: 14515994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.